BioSig Technologies Inc (OTCMKTS:BSGM) Director Donald E. Foley acquired 25,000 shares of the stock in a transaction on Tuesday, March 6th. The stock was purchased at an average cost of $1.42 per share, with a total value of $35,500.00. The transaction was disclosed in a document filed with the SEC, which is available through this link.

BioSig Technologies Inc (OTCMKTS:BSGM) traded up $0.04 during mid-day trading on Friday, hitting $1.44. 37,287 shares of the stock were exchanged, compared to its average volume of 32,173. BioSig Technologies Inc has a twelve month low of $1.20 and a twelve month high of $2.00.

Separately, Zacks Investment Research raised shares of BioSig Technologies from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research report on Friday, December 1st.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at

About BioSig Technologies

BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.

Insider Buying and Selling by Quarter for BioSig Technologies (OTCMKTS:BSGM)

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with's FREE daily email newsletter.